Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma.
Oliviero B, Varchetta S, Mele D, Pessino G, Maiello R, Falleni M, Tosi D, Donadon M, Soldani C, Franceschini B, Torzilli G, Piccolo G, Barabino M, Opocher E, Maestri M, Bernuzzi S, Wucherpfennig KW, Mondelli MU, Mantovani S. Oliviero B, et al. Among authors: wucherpfennig kw. Oncoimmunology. 2022 Feb 21;11(1):2035919. doi: 10.1080/2162402X.2022.2035919. eCollection 2022. Oncoimmunology. 2022. PMID: 35223192 Free PMC article.
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity.
Ferrari de Andrade L, Tay RE, Pan D, Luoma AM, Ito Y, Badrinath S, Tsoucas D, Franz B, May KF Jr, Harvey CJ, Kobold S, Pyrdol JW, Yoon C, Yuan GC, Hodi FS, Dranoff G, Wucherpfennig KW. Ferrari de Andrade L, et al. Among authors: wucherpfennig kw. Science. 2018 Mar 30;359(6383):1537-1542. doi: 10.1126/science.aao0505. Science. 2018. PMID: 29599246 Free PMC article.
A vaccine targeting resistant tumours by dual T cell plus NK cell attack.
Badrinath S, Dellacherie MO, Li A, Zheng S, Zhang X, Sobral M, Pyrdol JW, Smith KL, Lu Y, Haag S, Ijaz H, Connor-Stroud F, Kaisho T, Dranoff G, Yuan GC, Mooney DJ, Wucherpfennig KW. Badrinath S, et al. Among authors: wucherpfennig kw. Nature. 2022 Jun;606(7916):992-998. doi: 10.1038/s41586-022-04772-4. Epub 2022 May 25. Nature. 2022. PMID: 35614223 Free PMC article.
Discovering cancer immunotherapy targets in vivo.
Zhou P, Wucherpfennig KW. Zhou P, et al. Among authors: wucherpfennig kw. Oncoimmunology. 2014 Apr 17;3:e28500. doi: 10.4161/onci.28500. eCollection 2014. Oncoimmunology. 2014. PMID: 25050218 Free PMC article.
MHC-II neoantigens shape tumour immunity and response to immunotherapy.
Alspach E, Lussier DM, Miceli AP, Kizhvatov I, DuPage M, Luoma AM, Meng W, Lichti CF, Esaulova E, Vomund AN, Runci D, Ward JP, Gubin MM, Medrano RFV, Arthur CD, White JM, Sheehan KCF, Chen A, Wucherpfennig KW, Jacks T, Unanue ER, Artyomov MN, Schreiber RD. Alspach E, et al. Among authors: wucherpfennig kw. Nature. 2019 Oct;574(7780):696-701. doi: 10.1038/s41586-019-1671-8. Epub 2019 Oct 23. Nature. 2019. PMID: 31645760 Free PMC article.
231 results